Concepedia

Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections

Ingi Lee, Neil O. Fishman, Theoklis E. Zaoutis, Knashawn H. Morales, Mark G. Weiner, Marie Synnestvedt, Irving Nachamkin, Ebbing Lautenbach

Archives of Internal Medicine · 2009 · 81 citations · 28 references

DOIFull text

Open access

Abstract

Previous fluconazole use is a significant risk factor for health care-associated fluconazole-resistant C glabrata BSIs. Future studies will be needed to evaluate the effect of decreasing fluconazole use on rates of fluconazole-resistant C glabrata BSIs.

References

28

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

Hilmar Wisplinghoff, Thomas Bischoff, Sandra Tallent et al. · Clinical Infectious Diseases · 2004 · 4.5K citations · Full text

Infectious Diseases Society of America

J. F. Enders · The Journal of Infectious Diseases · 1969 · 3.3K citations

, , +18

THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION

RUTH M. MICKEY, Sander Greenland · American Journal of Epidemiology · 1989 · 2.3K citations

, , +22

RE:“;THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION”

Sander Greenland, Ruth M. Mickey · American Journal of Epidemiology · 1989 · 2.1K citations

Guidelines for Treatment of Candidiasis

Peter G. Pappas, John Rex, Jack D. Sobel et al. · Clinical Infectious Diseases · 2004 · 1.4K citations · Full text